BioTime, Inc. Share Price Nyse
Equities
US09066L1052
Biotechnology & Medical Research
Sales 2024 * | 12.53M 1.05B | Sales 2025 * | 6.17M 515M | Capitalization | 221M 18.44B |
---|---|---|---|---|---|
Net income 2024 * | -25M -2.09B | Net income 2025 * | -30M -2.5B | EV / Sales 2024 * | 17.6 x |
Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | 35.8 x |
P/E ratio 2024 * |
-8.36
x | P/E ratio 2025 * |
-7.8
x | Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 99.57% |
Latest transcript on BioTime, Inc.
Managers | Title | Age | Since |
---|---|---|---|
Brian Culley
CEO | Chief Executive Officer | 53 | 17/18/17 |
Jill Howe
DFI | Director of Finance/CFO | 48 | 14/22/14 |
Chief Operating Officer | - | 01/10/01 |
Members of the board | Title | Age | Since |
---|---|---|---|
Neal Bradsher
BRD | Director/Board Member | 58 | 01/09/01 |
Brian Culley
CEO | Chief Executive Officer | 53 | 17/18/17 |
Director/Board Member | 66 | 11/14/11 |
1st Jan change | Capi. | |
---|---|---|
+17.96% | 44.96B | |
+1.17% | 42.65B | |
+48.77% | 41.85B | |
-4.27% | 29.04B | |
+11.42% | 26.08B | |
-21.39% | 19.03B | |
+4.86% | 12.75B | |
+27.29% | 12.06B | |
-3.50% | 11.75B |